Clinical Trial: Y-6 Sublingual Tablets for Acute Penetrating Artery Infarction

U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07721545) titled 'Y-6 Sublingual Tablets for Acute Penetrating Artery Infarction' on July 10.

Brief Summary: The goal of this clinical trial is to learn if Y-6 sublingual tablets work to improve functional outcomes in patients with acute perforating artery infarction. It will also learn about the safety of Y-6 sublingual tablets.

The main questions it aims to answer are:

Does Y-6 sublingual tablets increase the proportion of participants who achieve a modified Rankin Scale (mRS) score of 0-1 at Day 90 after treatment? What medical problems do participants have when taking Y-6 sublingual tablets?

Researchers will compare different doses of Y-6 subl...